Quantum Materials Corp
Develops and manufactures Tetrapod Quantum Dots for medical diagnostics, display lighting, solar cells, and solid-state lighting through patent-pending volume production; also secured 3D printing technology for embedding quantum dots in products for uncopyable anti-counterfeiting identification.
- CEO / Founder
- Sriram Peruvemba
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $15M
- Latest Round
- Private Equity
- Key Investors
- Pasaca Capital
Technology & Products
Key Products
Tetrapod Quantum Dots (TQD) engineered for specific applications; TQD-infused films for medical devices, solid-state lighting, electronic displays, solar cells; 3D-printed quantum dot anti-counterfeiting detection technology; Volume quantum dot production services (from 1 gram to metric tons)
Technological Advantage
Proprietary automated manufacturing achieves economies of scale, uniform color purity, and high quantum yield—addressing the primary limitation competitors face with manual batch processes. 3D-printed quantum dot anti-counterfeiting is patented and difficult to replicate. Acquired Bayer Technology Services quantum dot manufacturing and solar cell patents, strengthening IP position.
Differentiation
Value Proposition
Proprietary automated volume production process enables consistent tetrapod quantum dot quality, scalable cost reduction, and uniform performance—addressing historical limitations of batch synthesis methods. 3D printing anti-counterfeiting application provides secure, uncloneable product identification by embedding quantum dots via additive manufacturing.
How They Differentiate
Automated volume production with consistent yield and color purity vs. competitors' manual batch synthesis. Cadmium-free formulation ahead of regulatory requirements. Unique 3D-printed anti-counterfeiting application with Virginia Tech patent protection. Broader application portfolio spanning medical, display, solar, and lighting vs. competitors focused on single verticals.
Market & Competition
Target Customers
Electronics manufacturers, display makers, solar cell developers, biotech companies, anti-counterfeiting solution providers, medical device manufacturers
Industry Verticals
Medical/biotech (diagnostic assays, drug delivery); Display (LCD, flexible printed electronics); Solar energy (photovoltaic cells); Lighting (LEDs, solid-state lighting); Anti-counterfeiting
Competitors
Nanocrystal Technology Corporation (batch synthesis quantum dots); Nanosys (acquired by Xiaoomi, LCD quantum dot solutions); QD Vision (OLED/display quantum dots)
Growth & Milestones
Growth Metrics
Expanded laboratory facility for research, development, and initial production in Texas; established wholly owned subsidiary Solterra Renewable Technologies for quantum dot solar development; $15M funding round (2021) enabled expanded Tetrapod Quantum Dot production; secured Bayer Technology Services patents; multiple global partnerships (Japan JETRO, Innova Medical); products passed GE, CE, ROHS, PAHS, TüV, REACH certifications.
Major Milestones
Founded January 2007 by Stephen Squires; Secured Virginia Tech 3D printing anti-counterfeiting technology partnership; Acquired Bayer Technology Services quantum dot patents; Established Solterra Renewable Technologies subsidiary (solar focus); Launched QMC HealthID with Innova Medical Group partnership; $15M private equity round from Pasaca Capital (February 2021); Established expanded laboratory facility in Texas for volume production; Solterra-JETRO partnership for Japan market introduction
Notable Customers
Leading LCD/display manufacturers (using cadmium-free TQD for compliance); Quantum dot solar cell research teams; Biotech companies developing diagnostic assays and drug delivery; Medical device manufacturers (TQD-infused films for diagnostic applications)